Keeping you up to date with reliable diabetes research, policy & guidance
Previous systematic reviews and meta-analyses have failed to turn up clear evidence on the benefits and harms of continuous glucose monitoring (CGM) in children with type 1 diabetes and insulin-using patients with type 2 diabetes. This systematic review set out to update this state of affairs in the light of recent studies. In children with [read the full story…]
Clinical question In patients with type 1 diabetes, does Continuous glucose monitoring (CGM) compared with self-management of blood glucose (SMBG) lead to an improvement in glycaemic control or a reduction in hypoglycemia? Methods Systematic review of randomised trials. 14 trials were found, comprising 1,268 participants. Bottom line Real-time CGM was associated with a 0.26% (95% [read the full story…]
This systematic review of randomised trials found nine studies that investigated whether continuous glucose monitoring (CGM) compared with self-monitoring of blood glucose (SMBG) led to improved glycaemic control or a reduction in hypoglycaemic episodes. The reviewers combined the results of the study in a meta-analysis to measure the benefit of CGM compared with conventional treatment [read the full story…]
